You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm expects full-year revenue growth of up to 39 percent, but fell short of prior guidance for the year.
Executives from Genomic Health, Meridian Bioscience, and Qiagen provided updates on their companies at the JP Morgan Healthcare Conference in San Francisco.
Developers said Illumina's decision to tap into the cancer screening market is not surprising because of its potentially huge size.
Executives from Luminex, Exact Sciences, T2 Biosystems, and Singulex provided updates on their companies' businesses on the final day of the conference.
Executives from several life science research tool and diagnostic firms provided conference attendees with updates on their businesses.
The chemistry will be single-molecule, based on hybridization, and will not require amplification, enzymes, or library prep, the firm said.
MedCity News says the real highlight of the JP Morgan Healthcare conference was when 23andMe CEO Anne Wojcicki was shushed for talking during her own company's presentation.
Executives from Thermo Fisher Scientific, Qiagen, Danaher, Counsyl, Human Longevity, and Adaptive Biotechnologies provided business updates to conference goers.
Executives from the sequencing tech firms provided attendees with an update on recently launched products and platforms, and future technology developments.
Executives from 23andMe, Myriad Genetics, Genomic Health, and Alere provided updates on their companies at the JP Morgan Healthcare Conference in San Francisco.
In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.
NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.
Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.
A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.